06/10/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 6/10/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the DTPM COVID-19 RT-PCR Test. The DTPM COVID-19 RT-PCR Test is authorized for use with nasopharyngeal, oropharyngeal, nasal, and mid-turbinate swab specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
No hay comentarios:
Publicar un comentario